Category: CovidienSyndicate content

Covidien acquires Reverse Medical | The week in medtech M&A

August 27, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien snaps up Reverse Medical; Report: Medtronic butts heads with shareholders at annual meeting; Allergan can't delay shareholder vote on hostile Valeant bid; Report: Allergan solicits Salix in bid to stymie hostile Valeant takeover; Report: Endo Health puts AMS up for sale

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

New roster: Medtronic, Covidien reveal regional integration teams

August 26, 2014 by Arezu Sarvestani

Medtronic and Covidien reveal the line-up of leaders slated to guide integration of the companies' regional divisions ahead of their $43 billion merger.

New roster: Medtronic, Covidien reveal regional integration teams

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic CEO targets 40% share of patient monitoring market after Covidien deal's close

August 26, 2014 by Brad Perriello

Medtronic CEO Omar Ishrak tells employees that its pending combination with Covidien lays the table for taking a 40% share of the patient monitoring market.

Medtronic CEO targets 40% share of patient monitoring market after Covidien deal's close

FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014

August 26, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Standard & Poor's maintains credit watch on Medtronic over Covidien buy

August 22, 2014 by Brad Perriello

Standard & Poor's Ratings Services maintains a credit watch on Medtronic over its $43 billion buyout of Covidien, pending Medtronic's ability to control its indebtedness.

Standard & Poor's puts credit watch on Medtronic over Covidien buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

Covidien snaps up Reverse Medical and its line of vascular devices for an unspecified amount.

YYmeta

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Medtronic butts heads with shareholders at annual meeting

August 22, 2014 by Arezu Sarvestani

Some of Medtronic's shareholders aren't pleased about the structure of the $43 billion mega-merger with Covidien, which will stick some long-time backers with significant fees.

Report: Medtronic butts heads with shareholders at annual meeting
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp